S&P 500   0.72 (+6.87%)
DOW   0.72 (+6.87%)
QQQ   271.86 (+2.52%)
AAPL   452.04 (+3.32%)
MSFT   209.19 (+2.86%)
FB   259.89 (+1.47%)
GOOGL   1,507.24 (+1.80%)
AMZN   3,162.24 (+2.65%)
NVDA   457.61 (+5.44%)
CGC   17.25 (+1.77%)
BABA   255.19 (+2.73%)
TSLA   1,554.76 (+13.12%)
GE   6.72 (-0.15%)
MU   48.48 (+1.51%)
AMD   82.61 (+7.45%)
T   30.18 (-0.07%)
F   7.11 (-1.66%)
ACB   9.80 (-2.20%)
GILD   68.84 (+1.09%)
NFLX   475.47 (+1.83%)
DIS   131.79 (+1.00%)
BAC   26.73 (-0.71%)
BA   175.44 (-2.60%)
S&P 500   0.72 (+6.87%)
DOW   0.72 (+6.87%)
QQQ   271.86 (+2.52%)
AAPL   452.04 (+3.32%)
MSFT   209.19 (+2.86%)
FB   259.89 (+1.47%)
GOOGL   1,507.24 (+1.80%)
AMZN   3,162.24 (+2.65%)
NVDA   457.61 (+5.44%)
CGC   17.25 (+1.77%)
BABA   255.19 (+2.73%)
TSLA   1,554.76 (+13.12%)
GE   6.72 (-0.15%)
MU   48.48 (+1.51%)
AMD   82.61 (+7.45%)
T   30.18 (-0.07%)
F   7.11 (-1.66%)
ACB   9.80 (-2.20%)
GILD   68.84 (+1.09%)
NFLX   475.47 (+1.83%)
DIS   131.79 (+1.00%)
BAC   26.73 (-0.71%)
BA   175.44 (-2.60%)
S&P 500   0.72 (+6.87%)
DOW   0.72 (+6.87%)
QQQ   271.86 (+2.52%)
AAPL   452.04 (+3.32%)
MSFT   209.19 (+2.86%)
FB   259.89 (+1.47%)
GOOGL   1,507.24 (+1.80%)
AMZN   3,162.24 (+2.65%)
NVDA   457.61 (+5.44%)
CGC   17.25 (+1.77%)
BABA   255.19 (+2.73%)
TSLA   1,554.76 (+13.12%)
GE   6.72 (-0.15%)
MU   48.48 (+1.51%)
AMD   82.61 (+7.45%)
T   30.18 (-0.07%)
F   7.11 (-1.66%)
ACB   9.80 (-2.20%)
GILD   68.84 (+1.09%)
NFLX   475.47 (+1.83%)
DIS   131.79 (+1.00%)
BAC   26.73 (-0.71%)
BA   175.44 (-2.60%)
S&P 500   0.72 (+6.87%)
DOW   0.72 (+6.87%)
QQQ   271.86 (+2.52%)
AAPL   452.04 (+3.32%)
MSFT   209.19 (+2.86%)
FB   259.89 (+1.47%)
GOOGL   1,507.24 (+1.80%)
AMZN   3,162.24 (+2.65%)
NVDA   457.61 (+5.44%)
CGC   17.25 (+1.77%)
BABA   255.19 (+2.73%)
TSLA   1,554.76 (+13.12%)
GE   6.72 (-0.15%)
MU   48.48 (+1.51%)
AMD   82.61 (+7.45%)
T   30.18 (-0.07%)
F   7.11 (-1.66%)
ACB   9.80 (-2.20%)
GILD   68.84 (+1.09%)
NFLX   475.47 (+1.83%)
DIS   131.79 (+1.00%)
BAC   26.73 (-0.71%)
BA   175.44 (-2.60%)
Log in

NASDAQ:UTMDUtah Medical Products Stock Price, Forecast & News

$84.15
+1.87 (+2.27 %)
(As of 08/13/2020 04:00 PM ET)
Add
Compare
Today's Range
$82.63
Now: $84.15
$84.73
50-Day Range
$80.70
MA: $85.25
$100.50
52-Week Range
$75.33
Now: $84.15
$112.26
Volume8,000 shs
Average Volume14,924 shs
Market Capitalization$306.56 million
P/E Ratio25.04
Dividend Yield1.33%
Beta0.35
Utah Medical Products, Inc. develops, manufactures, and distributes medical devices for the healthcare industry in the United States, Europe, and internationally. The company offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD, an infant respiratory hood; and DELTRAN PLUS, a blood pressure monitoring system. It also provides umbilical vessel catheters; DIALY-NATE, a disposable peritoneal dialysis set; PALA-NATE, a silicone oral protection device; URI-CATH, a urinary drainage system; MYELO-NATE, a lumbar sampling kit; and HEMO-NATE, a disposable filter. In addition, the company offers LETZ system to excise cervical intraepithelial neoplasia; FINESSE+ generators; loop, ball, and needle electrodes; FILTRESSE evacuators; other specialty electrodes and supplies, and gynecologic tools; Femcare trocars and cannulae; Femcare laparoscopic instruments and accessories; and EPITOME, an electrosurgical scalpel. Further, it provides FILSHIE CLIP system, a female surgical contraception; PATHFINDER PLUS, an endoscopic irrigation device; suprapubic catheterization; LIBERTY system to treat and control urinary incontinence in women; ENDOCURETTE, a curette for uterine endometrial tissue sampling; TVUS/HSG-Cath to assess abnormal or dysfunctional uterine bleeding and other suspected abnormalities of the uterus; and LUMIN to manipulate the uterus in laparoscopic procedures. Additionally, the company offers DELTRAN, a disposable pressure transducer; and pressure monitoring accessories, components, and other molded parts. It markets its products to neonatal intensive care unit, labor and delivery department, women's health center in hospitals, outpatient clinics, and physician's offices. The company sells its products through customer service and sales force, independent consultants, and independent manufacturer representatives. Utah Medical Products, Inc. was founded in 1978 and is headquartered in Midvale, Utah.
Read More
Utah Medical Products logo

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.2Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.77 out of 5 stars


Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryHealth Care Supplies
SectorMedical
Current SymbolNASDAQ:UTMD
CUSIP91748810
Phone801-566-1200

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$46.90 million
Cash Flow$5.89 per share
Book Value$27.17 per share

Profitability

Net Income$14.73 million

Miscellaneous

Employees173
Market Cap$306.56 million
Next Earnings Date10/22/2020 (Estimated)
OptionableNot Optionable
$84.15
+1.87 (+2.27 %)
(As of 08/13/2020 04:00 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive UTMD News and Ratings via Email

Sign-up to receive the latest news and ratings for UTMD and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Utah Medical Products (NASDAQ:UTMD) Frequently Asked Questions

How has Utah Medical Products' stock price been impacted by Coronavirus (COVID-19)?

Utah Medical Products' stock was trading at $88.50 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, UTMD stock has decreased by 4.9% and is now trading at $84.15.
View which stocks have been most impacted by COVID-19
.

When is Utah Medical Products' next earnings date?

Utah Medical Products is scheduled to release its next quarterly earnings announcement on Thursday, October 22nd 2020.
View our earnings forecast for Utah Medical Products
.

How were Utah Medical Products' earnings last quarter?

Utah Medical Products, Inc. (NASDAQ:UTMD) issued its quarterly earnings results on Thursday, April, 25th. The medical instruments supplier reported $0.84 earnings per share (EPS) for the quarter. The medical instruments supplier earned $10.73 million during the quarter. Utah Medical Products had a net margin of 28.44% and a return on equity of 12.33%.
View Utah Medical Products' earnings history
.

How often does Utah Medical Products pay dividends? What is the dividend yield for Utah Medical Products?

Utah Medical Products announced a quarterly dividend on Wednesday, August 12th. Stockholders of record on Tuesday, September 15th will be paid a dividend of $0.28 per share on Monday, October 5th. This represents a $1.12 annualized dividend and a dividend yield of 1.33%. The ex-dividend date of this dividend is Monday, September 14th.
View Utah Medical Products' dividend history
.

Has Utah Medical Products been receiving favorable news coverage?

Headlines about UTMD stock have trended negative this week, according to InfoTrie. The research firm identifies positive and negative press coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Utah Medical Products earned a coverage optimism score of -2.4 on InfoTrie's scale. They also assigned news stories about the medical instruments supplier a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an impact on the stock's share price in the next several days.
View the latest news about Utah Medical Products
.

Who are some of Utah Medical Products' key competitors?

What other stocks do shareholders of Utah Medical Products own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Utah Medical Products investors own include Simon Property Group (SPG), Walt Disney (DIS), UnitedHealth Group (UNH), Altria Group (MO), SEI Investments (SEIC), Trupanion (TRUP), Visa (V), Ventas (VTR), Axon Enterprise (AAXN) and AbbVie (ABBV).

Who are Utah Medical Products' key executives?

Utah Medical Products' management team includes the following people:
  • Mr. Kevin L. Cornwell, Chairman, CEO, Pres & Sec. (Age 72)
  • Mr. Brian L. Koopman, Principal Financial Officer & Controller

What is Utah Medical Products' stock symbol?

Utah Medical Products trades on the NASDAQ under the ticker symbol "UTMD."

Who are Utah Medical Products' major shareholders?

Utah Medical Products' stock is owned by a variety of institutional and retail investors. Top institutional investors include FMR LLC (15.00%), Russell Investments Group Ltd. (4.04%), Clean Yield Group (0.71%), Bank of New York Mellon Corp (0.63%), Raymond James & Associates (0.46%) and Natixis Advisors L.P. (0.42%). Company insiders that own Utah Medical Products stock include Barbara A Payne, Brian Koopman and Kevin L Cornwell.
View institutional ownership trends for Utah Medical Products
.

Which major investors are selling Utah Medical Products stock?

UTMD stock was sold by a variety of institutional investors in the last quarter, including UBS Group AG, California Public Employees Retirement System, Advisory Services Network LLC, Clean Yield Group, Cardinal Capital Management, US Bancorp DE, and Seizert Capital Partners LLC. Company insiders that have sold Utah Medical Products company stock in the last year include Barbara A Payne, Brian Koopman, and Kevin L Cornwell.
View insider buying and selling activity for Utah Medical Products
.

Which major investors are buying Utah Medical Products stock?

UTMD stock was acquired by a variety of institutional investors in the last quarter, including FMR LLC, Russell Investments Group Ltd., Globeflex Capital L P, Prudential Financial Inc., Natixis Advisors L.P., Janney Montgomery Scott LLC, Bank of New York Mellon Corp, and SG Americas Securities LLC.
View insider buying and selling activity for Utah Medical Products
.

How do I buy shares of Utah Medical Products?

Shares of UTMD can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Utah Medical Products' stock price today?

One share of UTMD stock can currently be purchased for approximately $84.15.

How big of a company is Utah Medical Products?

Utah Medical Products has a market capitalization of $306.56 million and generates $46.90 million in revenue each year. Utah Medical Products employs 173 workers across the globe.

What is Utah Medical Products' official website?

The official website for Utah Medical Products is www.utahmed.com.

How can I contact Utah Medical Products?

Utah Medical Products' mailing address is 7043 South 300 West, Midvale UT, 84047. The medical instruments supplier can be reached via phone at 801-566-1200.

This page was last updated on 8/13/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.